Literature DB >> 60218

The effect of propranolol on normal physiologic tremor.

D H Zilm, E M Sellers.   

Abstract

It has been demonstrated that intravenous propranolol produces a 34-60% decrease in normal physiological tremor. The decrease, in response to small doses of the drug (less than 12 mug/kg), was linearly proportional to the baseline tremor size and occurred only following a 10 min delay. It is possible that the effect on tremor is due to the formation of a highly specific centrally acting metabolite of propranolol.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 60218     DOI: 10.1016/0013-4694(76)90123-1

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  5 in total

1.  Central effects of the beta-adrenergic blocking agent acebutolol. A quantitative EEG study using normalised slope descriptors.

Authors:  K Kayed; O B Godtlibsen
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

2.  The effects of four antihypertensive agents on the Stroop colour-word test in normal male volunteer subjects.

Authors:  P G Harvey; A B Clayton; T A Betts
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

3.  Differential effects of propranolol on head and upper limb tremor in patients with essential tremor and dystonia.

Authors:  Giulia Paparella; Gina Ferrazzano; Antonio Cannavacciuolo; Francesco Cogliati Dezza; Giovanni Fabbrini; Matteo Bologna; Alfredo Berardelli
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

4.  Postural hand tremor and incident hypertension in young to middle-aged adults: the Bogalusa heart study.

Authors:  Tian Hu; Jack M Guralnik; Lu Yao; Jeanette Gustat; Emily W Harville; Larry S Webber; Wei Chen; Jiang He; Paul K Whelton; Lydia A Bazzano
Journal:  J Hypertens       Date:  2016-07       Impact factor: 4.844

5.  Beta-adrenergic modulation of tremor and corticomuscular coherence in humans.

Authors:  Mark R Baker; Stuart N Baker
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.